Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Stress Urinary Incontinence Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Are greater than 20 years of age.~* Are female outpatients.~* Present with SUI based on the disease diagnostic criteria, average at least one incontinent episode per day on the screening diary, and have had symptoms of SUI for a minimum of 3 months prior to study entry.~* Are women of non-childbearing potential by reason of hysterectomy, other surgery, or natural menopause, or are women of childbearing potential who test negative for pregnancy at the time of enrollment based on a urine pregnancy test and agree to use a medically accepted means of contraception (for example, intrauterine device \[IUD\], oral or injectable contraceptives, implant, barrier device, sterilization, abstinence, or sex with a vasectomized male partner) for the duration of the study. Women using oral contraceptives or hormone replacement therapy must have a stable dose and regimen for greater than or equal to 3 months prior to entry into the study.~* Have no language barrier, agree to comply with the requirements of the protocol, and sign a written informed consent document prior to entry into the study.~Exclusion Criteria:~* Suffer from severe constipation (for example, have impacted rectum at time of physical examination despite recent evacuation).~* Has a physical examination, neurological and/or vaginal examination results which, in the opinion of the investigator, should exclude the subject.~* Are on a medication regimen (including diuretics) for which dose and/or frequency has not been stable for at least 12 weeks prior to randomization, or is anticipated to change during the course of the study.~* Have had any major inpatient surgery within 3 months prior to study entry.~* Have current diagnosis of any of the following conditions, disorders, or diseases of the genito-urinary tract: Ureteric, bladder, urethral, or rectal fistula~* Uncorrected congenital abnormality leading to urinary incontinence~* Detrusor instability or noncompliant bladder~* Adult enuresis~* Voiding difficulty (i.e., subject complains of difficulty emptying their bladder).

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).